Introduction An estimated 281,550 women were diagnosed with invasive breast cancer and 49,290 women were diagnosed with in situ cancer in 2021 in the United States. One in eight women are expected to be diagnosed with breast cancer as compared…
Introduction The rare tumors of the breast are a heterogeneous group of typically triple-negative tumors. With some notable exceptions, these tumors are low grade and are relatively indolent despite their triple-negative status and frequent basal phenotype. These tumors can be…
Vascular Tumors Angiosarcoma Angiosarcomas (AS) are the most common sarcomas encountered in the breast. They account for <1% of all breast malignancies. They are divided into two categories: primary AS (idiopathic) and secondary AS. Secondary AS most often occur following…
Introduction Breast cancer is a heterogeneous disease process. The World Health Organization recognizes many morphologic subtypes. By gene expression, invasive breast cancer is classified into at least four major subtypes: luminal A, luminal B, human epidermal growth factor receptor 2…
Introduction Breast cancer is the leading cause of cancer death in women worldwide (15.5%). It is also the leading cause of cancer in women worldwide (24.5%). An estimated 276,480 women developed breast cancer in 2020. The estimated mortality is 42,170.…
Introduction Over the past several decades, the widespread adoption of mammographic screening has had a significant impact on the incidence, diagnosis, classification, and treatment of ductal carcinoma in situ (DCIS). There has been a vast increase in the publications with…